SEATTLE, June 03, 2021, (MEDGADGET) — Overview
A vaccine is a biological material that provides active acquired immunity against a specific infectious disease. Vaccines have so many types such as, attenuated, inactivated, subunit, toxoid, conjugate, experimental, heterotypic, and valence.
U.S. vaccines market is expected to account around US$ 19,355.2 Mn in terms of value in 2020 and is expected to account over US$ 27,947.4 Mn by the end of 2027.
For More Information, Request Sample Copy Of Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/4011
U.S. Vaccines Market: Drivers
Covid-19 exposure is expected to drive growth of the U.S. vaccines market during the forecast period. For instance, according to the World Health Organization report, in the U.S. from January 20, 2020 to 6:01 pm CEST, 6 July 2020, there have been 2,833,552 confirmed cases of COVID-19 with 129,408 deaths,
Furthermore, rising R&D initiatives for novel vaccines is also expected to propel growth of the U.S. vaccines market. For instance, in March 2020, IQVIA and Quest Diagnostics collaborated with the University of Texas Medical Branch through their joint venture Q2 Solutions to develop a novel assay for COVID-19 tests due to accelerate the production of a Coronavirus vaccine.
Human vaccine held a significant position in the U.S. vaccines market in 2019, accounting around 81.7% share in terms of value, followed by animal vaccine respectively.
U.S. Vaccines Market: Restraints
The U.S. vaccines market growth is expected to be hindered by the high cost of vaccine refrigeration. Refrigeration is necessary for vaccines to avoid chemical structure changes caused by contact with water and humidity, which may result in ineffective medications. Maintaining the cold chain from manufacturing to treatment is an expensive process that accounts for around 80% of the cost of vaccinations.
Furthermore, the low practical shelf life of certain vaccines, is also expected to hinder the U.S. vaccines market growth.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/4011
Developing a registry platform and database for COVID-19 is expected to pose attractive growth opportunities for key players in the U.S. vaccines market. For instance, in April 2020, Clara Health, a software startup, collaborated with Lyft, Inc., a ridesharing company, and VSC, a public relations agency, to create a registry platform and database that will link COVID-positive and -negative people to clinical trials for diagnostics, care, and vaccine development.
Furthermore, growing R&D initiatives in poultry is also expected to propel growth of the U.S. vaccines market. For instance, in May 2020, The U.S. Poultry Foundation awarded a US$ 7,000 grant to the University of North Georgia to recruit students into the poultry science program.
U.S. vaccines market was valued around US$ 18,367.0 Mn in 2019 and is forecast to reach a value over US$ 27,947.4 Mn by 2027 at a CAGR around 5.4% between 2020 and 2027.
Market Trends/Key Takeaways
Key players in the U.S. vaccines market are concentrating on adoption of merger and acquisition strategies to broaden their product portfolio. For instance, in April 2020, Sanofi Pasteur collaborated with GSK to develop an adjuvanted vaccine for COVID-19.
Vaccination-promoting regulations are expected to driving the U.S. vaccines market growth. For instance, the government of New Jersey, in the United States, required that college students be vaccinated against bacterial meningitis as a condition of attendance in January 2020.
- By Product Type:
- Human Vaccine: Pediatric Vaccines, Adult & Adolescent Vaccines, Other Human Vaccines.
- Animal Vaccine: Livestock Vaccines, Companion Animal Vaccines, Other Animal Vaccines.
- By End User: Hospitals, Clinics, and Vaccination Centers.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/us-vaccine-market-3281
The Center for Biologics Evaluation and Research (CBER) is the federal agency in charge of ensuring vaccine purity, protection, and effectiveness in the U.S.
U.S. Vaccines Market: Competitive Landscape
Key players are dominating in the U.S. vaccines market such as, GlaxoSmithKline Plc, Sanofi Pasteur, Pfizer Incorporated, Merck & Company Incorporated, Boehringer Ingelheim and AstraZeneca plc.
U.S. Vaccines Market: Key Developments
Key players in the U.S. vaccines market are concentrating on new vaccines approval and launches, to broaden their product range. For instance, in January 2020, Boehringer Ingelheim’s U.S. Animal Health Business launched a vaccine, VAXXITEK HVT+IBD+ND that offers protection against Marek’s Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease.
Moreover, in December 2019, NewLink Genetics Corporation received the U.S. FDA approval for ERVEBO or Zaire Ebola virus vaccine V920.
- U.S. Vaccine Market, By Product Type:
- Human Vaccine
- Pediatric Vaccines
- Adult & Adolescent Vaccines
- Other Human Vaccines
- Animal Vaccine
- Livestock Vaccines
- Companion Animal Vaccines
- Other Animal Vaccines
- Human Vaccine
- U.S. Vaccine Market, By End User:
- Vaccination Centers
- Company Profiles
Have a Look at Related Research Insights:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027